How to appeal your CVS Caremark step therapy override denial
Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. This guide is specific to CVS Caremark appeals.
Why CVS Caremark denies step therapy override
CVS Caremark is one of the three largest pharmacy benefit managers in the U.S., administering drug coverage for commercial, Medicare Part D, and Medicaid plans. Caremark denials are issued at the pharmacy benefit layer, separate from the medical benefit, and have their own appeal track.
For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.
Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
What CVS Caremark denies for step therapy override
The step therapy override services most often denied:
- Biologics for rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis
- MS disease-modifying therapies
- GLP-1s when a less-effective oral is preferred
- Newer migraine therapies (CGRP inhibitors)
- Specialty oncology when older regimens are preferred
Why step therapy override claims get denied
A typical CVS Caremark step therapy override denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:
- Patient has not tried and failed the preferred drug
- Documentation of prior trial / failure is incomplete
- Plan does not recognize prior trial done under previous plan
- Contraindication or intolerance not documented in record
The CVS Caremark appeal process
Appeal levels: Coverage determination / exception request, then plan-level redetermination, then external review (IRO for commercial; IRE / MAXIMUS for Medicare Part D).
Carrier timing: Standard exception requests: 72 hours commercial / 72 hours Part D. Expedited: 24 hours. Redetermination filing window: typically 60 days for Part D, 180 days for commercial.
Step therapy timing: Standard exception: typically 72 hours. Expedited urgent: 24 hours. Most state step-therapy override laws require response within 72 hours or less.
What we know about CVS Caremark: Caremark and the medical-benefit carrier (e.g. Aetna) maintain separate appeal records. We file in the correct lane from the start so the clock does not run on the wrong track.
Common CVS Caremark denial patterns for step therapy override
- Formulary and tiering exception requests. Most Caremark denials are formulary or tiering issues: a drug is non-formulary, on a higher tier, or subject to step therapy. The standard appeal lane is a formulary or tiering exception with the prescriber's clinical justification.
- Specialty drug prior authorization. High-cost specialty drugs (biologics, oncology, MS, RA) route through Caremark Specialty and require detailed clinical documentation. Manufacturer-supplied clinical dossiers and FDA label citations speed the exception process.
- Part D coverage determination ladder. For Medicare Part D plans administered by Caremark, denials follow the federal Part D appeal ladder: coverage determination → redetermination → IRE (MAXIMUS) → ALJ → Council → federal court. Each level has its own short deadline.
How to win your CVS Caremark step therapy override appeal
Strategy for step therapy override: File a step-therapy override request citing one of the standard override grounds: (1) prior trial and failure of the preferred drug, (2) contraindication to the preferred drug, (3) intolerance / adverse reaction, (4) likely-ineffective based on clinical characteristics, or (5) stability on current therapy. Attach prior pharmacy records from any plan to demonstrate prior trials. Many state laws now codify a tight response timeline for step-therapy overrides, cite the applicable statute.
Filed against CVS Caremark, that strategy rides on this procedural spine:
- Procedural-rights anchor. Every CVS Caremark denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter invokes these in the opening paragraph to lock the timeline and force criteria disclosure.
- Criteria-disclosure demand. CVS Caremark frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
- Controlling-standard citation. Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
- Treating-provider attestation. A letter from the treating physician addressing each criterion in CVS Caremark's own policy language. This is the single strongest evidentiary element.
- Requested action. A specific demand to reverse the step therapy override denial and approve the service, not a general "please reconsider."
Documents you'll need for your CVS Caremark step therapy override appeal
- Denial letter
- Prescription record from current and prior plans
- Prescriber's letter documenting clinical rationale and any prior trials
- Documentation of contraindication or intolerance (if applicable)
- Relevant lab values or imaging supporting indication
What a step therapy override appeal can recover
Typical recovery for step therapy override cases runs $500 - $30,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.
CVS Caremark step therapy override appeals: frequently asked questions
Can I get your CVS Caremark step therapy requirement waived?
Yes, through a step-therapy override request. Federal and many state laws require plans to grant an exception when the required first-line drug is clinically inappropriate for you.
What are the grounds for a step-therapy override?
Prior trial and failure of the preferred drug, a contraindication to it, an intolerance or adverse reaction, a clinical likelihood that it will be ineffective, or current stability on the prescribed therapy. Any one is sufficient.
How fast must CVS Caremark respond to an override request?
A standard exception is typically decided within 72 hours and an urgent one within 24 hours. Many state step-therapy laws codify a 72-hour-or-less response requirement.
What if my prior drug trial was under a different plan?
Bring it anyway. Pharmacy records from any prior plan can document a prior trial and failure; plans sometimes refuse to recognize outside trials, but the records are strong evidence on appeal.
What Apellica does for CVS Caremark step therapy override appeals
We file appeals against CVS Caremark specifically configured to its internal review process. Every step therapy override appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.
Cost: $0 upfront. We work on contingency for CVS Caremark appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your CVS Caremark step therapy override appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Related CVS Caremark guides
- CVS Caremark surgery denials appeal guide
- CVS Caremark mri and imaging denials appeal guide
- CVS Caremark medication and prescription denials appeal guide
- CVS Caremark medicare denials appeal guide